Lauren Fitzgerald, MD (“Dr. Fitz”) is a physician, entrepreneur, and wellness advocate dedicated to helping patients reclaim their health through an integrative, optimization-focused approach. A “recovering anesthesiologist,” she left the operating room in 2016 after years of practice in Texas, Oklahoma, and Japan to focus on prevention, longevity, and root-cause medicine. As Founder and CEO of Larimar Med in St. Charles, Illinois, Dr. Fitzgerald has built a “one-stop shop” for total body wellness that blends functional medicine, bioidentical hormone optimization, biohacking, advanced aesthetics, and IV nutrition therapies. She is known for her ability to translate complex science into practical, faith-aligned guidance, empowering patients to actively participate in their own healing and long-term vitality. A sought-after speaker, educator, and podcast guest, Dr. Fitzgerald uses social media and digital education to expand access to evidence-informed wellness, with a special focus on women’s health, hormones, and healthy aging. Grounded in her medical training and driven by a belief that “investing in you is the best investment you’ll ever make,” she continues to champion a model of healthcare that prioritizes optimization over disease management.
Lauren Fitzgerald
Continue exploring related topics.
VIEW ALLDr. Seeds’ Office Hours – Episode 095
1. Sjögren’s, POTS, Mold, Biofilms & Lumbrokinase (0:45)
2. PMDD, Allopregnanolone & Mitochondrial Efficiency (7:28)
3. Retatrutide, Glucagon & Metabolic Flexibility (20:01)
Cellular Optimization for EDS Surgical Support
Dr. Seeds reviews peptide and supplemental considerations for cellular optimization in an EDS patient preparing for orthopedic surgery. (Question Link)
The Phosphatidylcholine Pathway
Dr. Seeds expands on Journal Club Episode 92 to explore the role of phosphatidylcholine in lipid metabolism, methylation, and mitochondrial integrity during aging. He also highlights how estrogen loss may impact this pathway, especially in pre- and post-menopausal women.
Aging-Associated Decline of Phosphatidylcholine Synthesis is a Malleable Trigger of Natural Mitochondrial Aging
Dr. Seeds explores how age-related decline in phosphatidylcholine synthesis may contribute to mitochondrial aging and why that matters in Cellular Medicine. This discussion connects membrane integrity, mitochondrial function, methylation, and metabolic resilience, while highlighting how this pathway may be more modifiable than we once thought.
1. Managing shingles outbreaks in GLP-1 patient through peptides (0:40)
2. Peptide strategies in suspected ALS (15:56)
3. Improving durability in dementia treatment (25:08)